Cerus reported $-13.51M in EBITDA for its fiscal quarter ending in March of 2023.





Ebitda Change Date
GRIFOLS EUR 347.45M 210K Dec/2025
Haemonetics USD 94.78M 20.75M Dec/2025
Neogen USD 48.2M 546K Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Quidel USD 108.7M 44.6M Mar/2026
STAAR Surgical USD -159K 34.78M Dec/2025
Terumo JPY 57.88B 12.1B Mar/2026